NUS Nu Skin Enterprises Inc

Price (delayed)

$45.97

Market cap

$2.32B

P/E Ratio

20.34

Dividend/share

$1.53

EPS

$2.26

Enterprise value

$2.47B

Founded more than 35 years ago, Nu Skin Enterprises, Inc. empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its ...

Highlights
The quick ratio has soared by 54% year-on-year and by 48% since the previous quarter
NUS's equity is up by 2.5% year-on-year
The debt has increased by 10% since the previous quarter but it has declined by 4.5% year-on-year
The net income has dropped by 52% year-on-year and by 18% since the previous quarter
The company's EPS has shrunk by 51% YoY and by 18% QoQ

Key stats

What are the main financial stats of NUS
Market
Shares outstanding
50.38M
Market cap
$2.32B
Enterprise value
$2.47B
Valuations
Price to earnings (P/E)
20.34
Price to book (P/B)
2.45
Price to sales (P/S)
0.93
EV/EBIT
13.71
EV/EBITDA
8.28
EV/Sales
1
Earnings
Revenue
$2.48B
EBIT
$180.18M
EBITDA
$298.14M
Free cash flow
$142.24M
Per share
EPS
$2.26
Free cash flow per share
$2.82
Book value per share
$18.74
Revenue per share
$49.24
TBVPS
$32.2
Balance sheet
Total assets
$1.9B
Total liabilities
$959.87M
Debt
$517.34M
Equity
$941.04M
Working capital
$498.75M
Liquidity
Debt to equity
0.55
Current ratio
2.3
Quick ratio
1.11
Net debt/EBITDA
0.51
Margins
EBITDA margin
12%
Gross margin
74.1%
Net margin
4.6%
Operating margin
7.6%
Efficiency
Return on assets
5.9%
Return on equity
12.2%
Return on invested capital
13.8%
Return on capital employed
11.9%
Return on sales
7.3%
Dividend
Dividend yield
3.33%
DPS
$1.53
Payout ratio
67.7%

NUS stock price

How has the Nu Skin Enterprises stock price performed over time
Intraday
1.14%
1 week
6.04%
1 month
8.52%
1 year
-13.3%
YTD
-9.42%
QTD
6.17%

Financial performance

How have Nu Skin Enterprises's revenue and profit performed over time
Revenue
$2.48B
Gross profit
$1.84B
Operating income
$189.38M
Net income
$113.45M
Gross margin
74.1%
Net margin
4.6%
The net income has dropped by 52% year-on-year and by 18% since the previous quarter
The net margin has declined by 45% year-on-year and by 13% since the previous quarter
The company's operating income fell by 39% YoY and by 15% QoQ
Nu Skin Enterprises's operating margin has decreased by 31% YoY and by 11% QoQ

Growth

What is Nu Skin Enterprises's growth rate over time

Valuation

What is Nu Skin Enterprises stock price valuation
P/E
20.34
P/B
2.45
P/S
0.93
EV/EBIT
13.71
EV/EBITDA
8.28
EV/Sales
1
The company's EPS has shrunk by 51% YoY and by 18% QoQ
The price to earnings (P/E) is 30% more than the last 4 quarters average of 15.7 and 7% more than the 5-year quarterly average of 19.0
The P/B is 28% below the 5-year quarterly average of 3.4 and 2% below the last 4 quarters average of 2.5
NUS's equity is up by 2.5% year-on-year
The price to sales (P/S) is 15% lower than the 5-year quarterly average of 1.1 but 3.3% higher than the last 4 quarters average of 0.9
NUS's revenue is down by 12% YoY and by 5% from the previous quarter

Efficiency

How efficient is Nu Skin Enterprises business performance
The company's return on equity has shrunk by 55% YoY and by 19% QoQ
The ROA has plunged by 52% YoY and by 17% from the previous quarter
The return on invested capital has declined by 46% year-on-year and by 19% since the previous quarter
The company's return on sales fell by 34% YoY and by 12% QoQ

Dividends

What is NUS's dividend history
DPS
$1.53
Dividend yield
3.33%
Payout ratio
67.7%
Recent dividends

Financial health

How did Nu Skin Enterprises financials performed over time
The total assets is 98% more than the total liabilities
The quick ratio has soared by 54% year-on-year and by 48% since the previous quarter
NUS's current ratio is up by 47% year-on-year and by 34% since the previous quarter
The debt is 45% smaller than the equity
The debt to equity has grown by 10% since the previous quarter but it has declined by 7% year-on-year
The debt has increased by 10% since the previous quarter but it has declined by 4.5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.